3/13
05:37 am
lmat
3 Healthcare Stocks We're Skeptical Of [Yahoo! Finance]
Low
Report
3 Healthcare Stocks We're Skeptical Of [Yahoo! Finance]
3/12
06:10 am
lmat
LeMaitre Vascular (LMAT) was upgraded by
Weiss Ratings from "hold (c+)" to "buy (b-)".
Low
Report
LeMaitre Vascular (LMAT) was upgraded by
Weiss Ratings from "hold (c+)" to "buy (b-)".
3/5
08:27 am
lmat
2 Profitable Stocks with Exciting Potential and 1 We Turn Down [Yahoo! Finance]
Low
Report
2 Profitable Stocks with Exciting Potential and 1 We Turn Down [Yahoo! Finance]
3/2
12:12 pm
lmat
LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross [Yahoo! Finance]
Low
Report
LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross [Yahoo! Finance]
3/2
07:35 am
lmat
LeMaitre Vascular (LMAT) Is Up 16.4% After Dividend Hike And Buyback Plan – Has The Bull Case Changed? [Yahoo! Finance]
Low
Report
LeMaitre Vascular (LMAT) Is Up 16.4% After Dividend Hike And Buyback Plan – Has The Bull Case Changed? [Yahoo! Finance]
3/1
10:42 am
lmat
How The LeMaitre Vascular (LMAT) Investment Story Is Evolving With New Targets And Guidance [Yahoo! Finance]
Low
Report
How The LeMaitre Vascular (LMAT) Investment Story Is Evolving With New Targets And Guidance [Yahoo! Finance]
2/28
08:33 am
lmat
LeMaitre Vascular, Inc. (LMAT): A Bull Case Theory [Yahoo! Finance]
Low
Report
LeMaitre Vascular, Inc. (LMAT): A Bull Case Theory [Yahoo! Finance]
2/27
03:22 pm
lmat
LeMaitre to Participate at Upcoming Investor Conferences in March [Yahoo! Finance]
Low
Report
LeMaitre to Participate at Upcoming Investor Conferences in March [Yahoo! Finance]
2/27
03:05 pm
lmat
LeMaitre Vascular: The Compounder Keeps Compounding [Seeking Alpha]
Low
Report
LeMaitre Vascular: The Compounder Keeps Compounding [Seeking Alpha]
2/27
02:50 pm
lmat
LeMaitre to Participate at Upcoming Investor Conferences in March
Low
Report
LeMaitre to Participate at Upcoming Investor Conferences in March
2/26
05:36 pm
lmat
LeMaitre Vascular (LMAT) had its price target raised by Barrington Research from $95.00 to $105.00. They now have an "outperform" rating on the stock.
Medium
Report
LeMaitre Vascular (LMAT) had its price target raised by Barrington Research from $95.00 to $105.00. They now have an "outperform" rating on the stock.
2/26
12:53 pm
lmat
LeMaitre Vascular (LMAT) had its "buy" rating reaffirmed by Roth Mkm. They now have a $117.00 price target on the stock, up from $108.00.
Medium
Report
LeMaitre Vascular (LMAT) had its "buy" rating reaffirmed by Roth Mkm. They now have a $117.00 price target on the stock, up from $108.00.
2/26
11:52 am
lmat
LeMaitre Vascular (LMAT) had its price target raised by Wells Fargo & Company from $87.00 to $94.00. They now have an "equal weight" rating on the stock.
Medium
Report
LeMaitre Vascular (LMAT) had its price target raised by Wells Fargo & Company from $87.00 to $94.00. They now have an "equal weight" rating on the stock.
2/26
09:55 am
lmat
LeMaitre Vascular (LMAT) had its price target raised by Citizens Jmp from $113.00 to $118.00. They now have a "market outperform" rating on the stock.
Medium
Report
LeMaitre Vascular (LMAT) had its price target raised by Citizens Jmp from $113.00 to $118.00. They now have a "market outperform" rating on the stock.
2/26
12:27 am
lmat
LeMaitre Vascular raises dividend by 25% to $0.25 [Seeking Alpha]
High
Report
LeMaitre Vascular raises dividend by 25% to $0.25 [Seeking Alpha]
2/26
12:13 am
lmat
LeMaitre Vascular Inc (LMAT) Q4 2025 Earnings Call Highlights: Robust Growth and Strategic ... [Yahoo! Finance]
High
Report
LeMaitre Vascular Inc (LMAT) Q4 2025 Earnings Call Highlights: Robust Growth and Strategic ... [Yahoo! Finance]
2/25
06:12 pm
lmat
LeMaitre Vascular (LMAT) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
High
Report
LeMaitre Vascular (LMAT) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
2/25
05:16 pm
lmat
LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars [Yahoo! Finance]
High
Report
LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars [Yahoo! Finance]
2/25
04:05 pm
lmat
LeMaitre Q4 2025 Financial Results
High
Report
LeMaitre Q4 2025 Financial Results
2/20
08:03 am
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
2/11
09:47 am
lmat
LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026
Low
Report
LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026
2/9
05:36 am
lmat
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Expensive For A Reason? A Look At Its Intrinsic Value [Yahoo! Finance]
Low
Report
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Expensive For A Reason? A Look At Its Intrinsic Value [Yahoo! Finance]
1/6
01:21 pm
lmat
Do LeMaitre Vascular's (NASDAQ:LMAT) Earnings Warrant Your Attention? [Yahoo! Finance]
Low
Report
Do LeMaitre Vascular's (NASDAQ:LMAT) Earnings Warrant Your Attention? [Yahoo! Finance]
1/3
05:42 am
lmat
LeMaitre Vascular (NASDAQ:LMAT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
12/25
09:20 pm
lmat
Reflecting On Surgical Equipment & Consumables - Specialty Stocks' Q3 Earnings: LeMaitre (NASDAQ:LMAT) [Yahoo! Finance]
Low
Report
Reflecting On Surgical Equipment & Consumables - Specialty Stocks' Q3 Earnings: LeMaitre (NASDAQ:LMAT) [Yahoo! Finance]